UCB's Global Corporate Website
Welcome to UCB in the United States

Categories

Archives

Oct

13

UCB Reinforces Commitment to Advancing Care in Hidradenitis Suppurativa with Six Abstracts at SHSA 2023

Read More Share:linkedin| twitter| email

Oct

13

Going Beyond the Medicine: How UCB Is Addressing the Needs of People Living with Hidradenitis Suppurativa

Read More Share:linkedin| twitter| email

Oct

12

Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa

Read More Share:linkedin| twitter| email

Oct

04

UCB presents late-breaking posters at Child Neurology Society Meeting

Read More Share:linkedin| twitter| email

Oct

02

“Disease modification” in epilepsies: key questions answered

Read More Share:linkedin| twitter| email

Sep

28

Employee Spotlight: Jessie Kim's Journey as a Global Regulatory Fellow

Read More Share:linkedin| twitter| email

Sep

12

Disease Spotlight: Thymidine Kinase 2 Deficiency (TK2d)

Read More Share:linkedin| twitter| email

Sep

11

UCB PharmD Second-Year Fellows Share Reflections and Advice

Read More Share:linkedin| twitter| email

Sep

05

Announcing the 2023 UCB Family Epilepsy Scholarship Winners

Read More Share:linkedin| twitter| email

Aug

28

Breaking Down the Value Chain: Patient Voices Advocating for Change

Read More Share:linkedin| twitter| email

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)